125 related articles for article (PubMed ID: 15928252)
1. Overexpression of immediate early genes in active Graves' ophthalmopathy.
Lantz M; Vondrichova T; Parikh H; Frenander C; Ridderstråle M; Asman P; Aberg M; Groop L; Hallengren B
J Clin Endocrinol Metab; 2005 Aug; 90(8):4784-91. PubMed ID: 15928252
[TBL] [Abstract][Full Text] [Related]
2. Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.
Planck T; Shahida B; Sjögren M; Groop L; Hallengren B; Lantz M
Thyroid; 2014 Jul; 24(7):1156-61. PubMed ID: 24780075
[TBL] [Abstract][Full Text] [Related]
3. COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy.
Vondrichova T; de Capretz A; Parikh H; Frenander C; Asman P; Aberg M; Groop L; Hallengren B; Lantz M
Thyroid; 2007 Jun; 17(6):511-7. PubMed ID: 17614770
[TBL] [Abstract][Full Text] [Related]
4. Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.
Planck T; Shahida B; Parikh H; Ström K; Åsman P; Brorson H; Hallengren B; Lantz M
Thyroid; 2014 Oct; 24(10):1524-32. PubMed ID: 25135760
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.
Kumar S; Leontovich A; Coenen MJ; Bahn RS
J Clin Endocrinol Metab; 2005 Aug; 90(8):4730-5. PubMed ID: 15886250
[TBL] [Abstract][Full Text] [Related]
6. Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.
Woo YJ; Seo Y; Kim JJ; Kim JW; Park Y; Yoon JS
Ocul Immunol Inflamm; 2018; 26(7):1094-1100. PubMed ID: 28548552
[TBL] [Abstract][Full Text] [Related]
7. Gene expression in Graves' ophthalmopathy and arm lymphedema: similarities and differences.
Planck T; Parikh H; Brorson H; Mårtensson T; Åsman P; Groop L; Hallengren B; Lantz M
Thyroid; 2011 Jun; 21(6):663-74. PubMed ID: 21510802
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling.
Wei YH; Liao SL; Wang CC; Wang SH; Tang WC; Yang CH
Mediators Inflamm; 2021; 2021():8888913. PubMed ID: 33542676
[TBL] [Abstract][Full Text] [Related]
9. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
Kumar S; Coenen MJ; Scherer PE; Bahn RS
J Clin Endocrinol Metab; 2004 Feb; 89(2):930-5. PubMed ID: 14764816
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
[TBL] [Abstract][Full Text] [Related]
13. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
[TBL] [Abstract][Full Text] [Related]
14. Serum CYR61 Levels are Associated with Graves' Ophthalmopathy and Smoking in Patients with Graves' Disease.
Cerri P; Shahida B; Lantz M; Planck T
Horm Metab Res; 2022 Mar; 54(3):168-174. PubMed ID: 35276742
[TBL] [Abstract][Full Text] [Related]
15. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
[TBL] [Abstract][Full Text] [Related]
16. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
[TBL] [Abstract][Full Text] [Related]
17. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.
Kumar S; Bahn RS
J Clin Endocrinol Metab; 2003 Sep; 88(9):4246-50. PubMed ID: 12970294
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of endocrine ophthalmopathy].
Rødahl E; Seland J; Olofsson J; Aanderud S; Kråkenes J
Tidsskr Nor Laegeforen; 1999 May; 119(12):1737-42. PubMed ID: 10380588
[TBL] [Abstract][Full Text] [Related]
20. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
